Overall, our study highlights a pivotal role of TNF signaling in SAVI disease and implies TNF blockade as valuable therapeutic option to ameliorate symptoms of SAVI disease in patients. This evidence concerns the gene TNF and STING-associated vasculopathy with onset in infancy.